IL10 and Burkitt lymphoma: They can increase tumorigenicity, promote cell survival, induce interleukin-10 (IL-10) expression in BL cell lines [103,104,105], and significantly enhance the tumorigenicity of EBV-negative BL cells in SCID mice [106].